GILL DAVID N 4
Research Summary
AI-generated summary
Evolus (EOLS) Director David N. Gill Receives RSU Award
What Happened
David N. Gill, a director of Evolus, was granted 45,559 restricted stock units (RSUs) on February 17, 2026. The Form 4 shows an acquisition type "A" at $0.00 per share (total reported value $0) because RSUs are contingent awards rather than cash purchases. These RSUs convert to one share each upon vesting.
Key Details
- Transaction date: 2026-02-17; Form 4 filed: 2026-02-19 (timely filing).
- Grant: 45,559 RSUs; reported price per share: $0.00; reported cash value at grant: $0.
- Shares owned after transaction: not specified in the provided filing.
- Footnote: RSUs vest in full on the one-year anniversary of Feb 17, 2026 (i.e., Feb 17, 2027) provided continuous service; vesting may accelerate in certain events (including certain change-of-control scenarios).
- Transaction code: A = Award/Acquisition of stock-based compensation.
Context
RSUs are a form of equity compensation that give the recipient a contingent right to receive shares in the future (typically taxed when they vest). Because no shares were purchased or sold on the open market and no cash changed hands at grant, this transaction reflects compensation rather than a market vote by the insider. Vesting and any accelerated vesting terms determine when shares will be delivered.